Bioequivalence Study of Rosuvastatin Tablet

NACompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

November 24, 2022

Primary Completion Date

December 6, 2022

Study Completion Date

December 15, 2022

Conditions
Healthy Individuals
Interventions
DRUG

Test Drug

One single dose of Vaptor 20 mg will be administered to subjects after at least 10 hours fast together with 240 mL of ambient temperature water at their scheduled dosing time.

DRUG

Reference Drug

One single dose of Crestor 20 mg will be administered to subjects after at least 10 hours fast together with 240 mL of ambient temperature water at their scheduled dosing time.

Trial Locations (1)

75270

Muhammad Raza Shah, Karachi

All Listed Sponsors
collaborator

The Searle Company Limited

UNKNOWN

lead

University of Karachi

OTHER